Press Releases Events & Presentations Event Details EASL 2022 – The International Liver Conference Jun 22 - Jun 26, 2022 Supporting Materials ABI-H3733 – New Tablet Formulation 396.2 KB ABI-4334 – Preclinical Characterization 577.2 KB Vebicorvir – Virologic Suppression and Fibrosis-4 Index 580.1 KB Vebicorvir – Viral Sequence Diversity During Treatment and Rebound 814 KB Vebicorvir – Drug-drug Interaction Profile 993.6 KB Vebicorvir – Disposition and Mass Balance 512.1 KB Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
EASL 2022 – The International Liver Conference Jun 22 - Jun 26, 2022 Supporting Materials ABI-H3733 – New Tablet Formulation 396.2 KB ABI-4334 – Preclinical Characterization 577.2 KB Vebicorvir – Virologic Suppression and Fibrosis-4 Index 580.1 KB Vebicorvir – Viral Sequence Diversity During Treatment and Rebound 814 KB Vebicorvir – Drug-drug Interaction Profile 993.6 KB Vebicorvir – Disposition and Mass Balance 512.1 KB
